# aTYR PHARMA INC: Form 8-K, filed May 19, 2023

- Company: [aTYR PHARMA INC](/companies/atyr.md) (CIK 1339970)
- Form: 8-K
- Filed: 2023-05-19
- Accepted by EDGAR: May 19, 2023, 16:17 ET
- Period: 2023-05-17
- Accession: 0000950170-23-023257
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1339970/000095017023023257/life-20230517.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1339970/000095017023023257/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.05: Item not in the standard list
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1339970/000095017023023257/life-20230517.htm

Filed May 19, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-023257. Last ingested by Listed: Nov 6, 2026, 16:47 ET. No prices; not investment advice.